EVALUATION OF ANTIPSYCHOTIC DRUGS IN RELATION TO THEIR EFFECT ON METABOLIC RISK FACTORS

被引：0
|
作者：
Jindel, A. [1 ]
Yadav, D. [1 ]
Mishra, S. [1 ]
Sharma, P. [1 ]
机构：
[1] SMS Med Coll & Hosp, Dept Biochem, Jaipur 302004, Rajasthan, India
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2011年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：S384 / S384
页数：1
相关论文
共 50 条
  • [1] EVALUATION OF ANTIPSYCHOTIC DRUGS IN RELATION TO THEIR EFFECT ON METABOLIC RISK FACTORS
    Aditi, Gupta
    Dharamveer, Yadav
    Sandhya, Mishra
    Monika, Gupta
    Praveen, Sharma
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S619 - S619
  • [2] Antipsychotic drugs -: Risk factors for diabetes
    Stip, E
    Tranulis, C
    Légaré, N
    Poulin, MJ
    PRESSE MEDICALE, 2003, 32 (34): : 1612 - 1617
  • [3] Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: A controlled study
    Jennex, Amber
    Gardner, David M.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2008, 53 (01): : 34 - 42
  • [4] Identification of risk factors and metabolic monitoring practices in patients on antipsychotic drugs in South India
    Poojari, Pooja Gopal
    Khan, Sohil A.
    Shenoy, Sonia
    Acharya, Leelavathi D.
    Shetty, Sahana
    Bose, Swarnali
    Pai, Keshava
    Kunhikatta, Vijayanarayana
    Thunga, Girish
    ASIAN JOURNAL OF PSYCHIATRY, 2020, 53
  • [5] Thrombotic complications of treatment with antipsychotic drugs : risk factors
    Abid, W.
    Cherif, F.
    Bouattour, N.
    Masmoudi, R.
    Guermazi, F.
    Feki, I.
    Sallemi, R.
    Masmoudi, J.
    EUROPEAN PSYCHIATRY, 2023, 66 : S590 - S590
  • [6] Metabolic effects of antipsychotic drugs
    Davis, Vanessa
    Rosenbloom, Arlan L.
    PEDIATRIC DIABETES, 2006, 7 (03) : 176 - 186
  • [7] Metabolic risk factors, drugs, and obesity
    Padwal, R
    Majumdar, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09): : 974 - 975
  • [8] Antipsychotic drugs and metabolic disorders
    Vasileios Athyros
    Annals of General Psychiatry, 5 (Suppl 1)
  • [9] High prevalence of metabolic risk factors associated with cardiovascular disease in schizophrenic patients treated with atypical antipsychotic drugs
    Larsen, JT
    Fagerquist, M
    Holdrup, M
    Christensen, B
    Sigalin, C
    Nilsson, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S512 - S513
  • [10] Metabolic Consequences of Atypical Antipsychotic Drugs
    Harold E. Lebovitz
    Psychiatric Quarterly, 2003, 74 : 277 - 290
12345